Home » Stocks » PKI

PerkinElmer, Inc. (United States) (PKI)

Stock Price: $151.19 USD 1.97 (1.32%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $151.29 +0.10 (0.07%) Jan 20, 7:53 PM
Market Cap 16.94B
Revenue (ttm) 3.23B
Net Income (ttm) 412.03M
Shares Out 111.68M
EPS (ttm) 3.69
PE Ratio 40.98
Forward PE 18.08
Dividend $0.28
Dividend Yield 0.19%
Trading Day January 20
Last Price $151.19
Previous Close $149.22
Change ($) 1.97
Change (%) 1.32%
Day's Open 150.09
Day's Range 149.72 - 152.07
Day's Volume 616,912
52-Week Range 66.54 - 160.46

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 2 days ago

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.

Zacks Investment Research - 6 days ago

Top Ranked Growth Stocks to Buy for January 14th

Other stocks mentioned: BJ, GM, HOLX
Business Wire - 6 days ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from t...

Business Wire - 1 week ago

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oxford I...

Zacks Investment Research - 1 week ago

PerkinElmer's (PKI) acquisition of Oxford Immunotec will expand its portfolio of advanced infectious disease testing solutions.

Market Watch - 1 week ago

Shares of PerkinElmer Inc. rose 1.2% toward record territory in premarket trading Monday, after the life sciences diagnostics company provided an upbeat fourth-quarter earnings outlook, citing...

Business Wire - 1 week ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue ...

Zacks Investment Research - 1 week ago

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

Investors Business Daily - 1 week ago

Oxford Immunotec Global shares surged Thursday after PerkinElmer agreed to buy the diagnostics-focused medical stock for $591 million. This follows its plan to buy Horizon Discovery.

Other stocks mentioned: OXFD
Business Wire - 1 week ago

WALTHAM, Mass. & LONDON--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or the “Company”) are pleased to anno...

Other stocks mentioned: OXFD
The Motley Fool - 2 weeks ago

PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company?

Zacks Investment Research - 1 month ago

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

Business Wire - 1 month ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. ...

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for December 11th

Other stocks mentioned: GM, HOLX, OMI
Zacks Investment Research - 1 month ago

Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 month ago

Top Ranked Growth Stocks to Buy for December 8th

Other stocks mentioned: AVT, FHI, HOLX
Zacks Investment Research - 1 month ago

PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 1 month ago

It will be prudent to invest in Zacks top-Ranked S&P 500 stocks that have skyrocketed year to date with strong potential for 2021. These include DE, HOLX, LB, PKI, IPGP, QRVO.

Other stocks mentioned: DE, HOLX, IPGP, LB, QRVO
Zacks Investment Research - 1 month ago

We have narrowed our search to five mid-cap stocks that have become large caps during the coronavirus hit past eight and a half months. These are: SAM, LB, PKI, UI, GNRC.

Other stocks mentioned: GNRC, LB, SAM, UI
CNBC Television - 1 month ago

Final Trades: Alphabet, PerkinElmer, Ulta Beauty & more

The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to C...

Other stocks mentioned: GOOG, GOOGL, ULTA, JMIA
Zacks Investment Research - 1 month ago

Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.

Other stocks mentioned: HOLX, LH, TMO
Zacks Investment Research - 1 month ago

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

Business Wire - 1 month ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., announced today the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company's c...

Seeking Alpha - 1 month ago

PerkinElmer has been a huge beneficiary of Covid-19 thanks to its diagnostics business. Shares have done well this year, but momentum has been reasonable.

Zacks Investment Research - 2 months ago

PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 2 months ago

Americas CarMart (CRMT), Best Buy (BBY), IDEXX Laboratories (IDXX) and PerkinElmer (PKI) currently flaunt striking earnings growth and positive estimate revisions.

Other stocks mentioned: BBY, CRMT, IDXX
Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. announced today that its PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and th...

Zacks Investment Research - 2 months ago

As of late, it has definitely been a great time to be an investor in PerkinElmer (PKI).

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science...

Zacks Investment Research - 2 months ago

PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer introduces new LC solution bringing together advanced HPLC and UHPLC capabilities with intuitive instrument control and data analysis.

Zacks Investment Research - 2 months ago

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. today launched its newest ChemDraw® application, ChemOffice®+ Cloud, to accelerate chemistry communication workflows.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launch...

Zacks Investment Research - 2 months ago

Sales growth is a major indicator of a company's health and ability to sustain business. Let's check out - Tapestry (TPR), Newmont (NEM), Teradyne (TER), Aarons (AAN) & PerkinElmer (PKI) - as ...

Other stocks mentioned: AAN, NEM, TER, TPR
CNBC Television - 2 months ago

Cramer on four coronavirus testing stocks worth owning

"I bet the testing stocks have a lot more room to run," the "Mad Money" host said.

Other stocks mentioned: ABT, DGX, FLDM, HOLX, LH, QDEL, TMO
Zacks Investment Research - 2 months ago

PerkinElmer (PKI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Virtua...

Zacks Investment Research - 2 months ago

PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtu...

Zacks Investment Research - 2 months ago

Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million).

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample poo...

Zacks Investment Research - 2 months ago

PerkinElmer's (PKI) third-quarter results benefit from growth in Diagnostics segment. However, forex remains a woe.

Seeking Alpha - 2 months ago

PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q3 2020 Results - Earnings Call Transcript

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended Octo...

Zacks Investment Research - 2 months ago

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Launches immunoassay to help in researcher's fight against neurodegenerative diseases such as Parkinson's and Alzheimer's.

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnost...

Business Wire - 2 months ago

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020. This divide...

About PKI

PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and se... [Read more...]

Industry
Diagnostics & Research
Founded
1937
CEO
Prahlad Singh
Employees
13,000
Stock Exchange
NYSE
Ticker Symbol
PKI
Full Company Profile

Financial Performance

In 2019, PerkinElmer's revenue was $2.88 billion, an increase of 3.80% compared to the previous year's $2.78 billion. Earnings were $227.56 million, a decrease of -4.36%.

Financial Statements

Analyst Forecasts

According to 16 analysts, the average rating for PerkinElmer stock is "Buy." The 12-month stock price forecast is 155.40, which is an increase of 2.78% from the latest price.

Price Target
$155.40
(2.78% upside)
Analyst Consensus: Buy